Atrial fibrillation in mechanical circulatory support patients

Abstract

Atrial fibrillation (AF) is known to be one of the most common arrhythmias noted in cardiac procedures and is frequently associated with heart failure. As frequent interventions for patients with heart failure involve implantation of mechanical circulatory assist devices (e.g., left ventricular assist devices), it is timely to review the role this arrhythmia has on adverse clinical outcomes. A comprehensive literature search was conducted for PubMed. Relevant medical subject heading (MeSH) terms used in the initial literature search include “Heart-Assist Devices”, “Extracorporeal Membrane Oxygenation”, “Atrial Fibrillation”, “Heart Failure”, “Mortality”, “Hospital Readmission”, “stroke”, “Postoperative Complications”. In this review, the relevant literature was highlighted to identify the incidence, clinical impacts, and management of AF surrounding mechanical circulatory support implantation. The incidence of AF in this mechanical circulatory support device population was similar to that of patients with other cardiac procedures (10%-40%). Moreover, in most studies, preoperative AF was not significantly associated with adverse outcomes. In contrast, however, it appears that postoperative atrial fibrillation may predispose patients to increased risk for thromboembolic events and adverse long-term outcomes.

Keywords

Atrial fibrillation / mechanical circulatory support / left ventricular assist device / extracorporeal membrane oxygenation / impella

References

[1] Skanes AC.Atrial fibrillation and heart failure: untangling a modern gordian knot.Can J Cardiol2018;34:1437-48

[2] Boyle NG.Atrial fibrillation in congestive heart failure: current management.Cardiol Clin2009;27:79-93

[3] Maisel WH.Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy.The American Journal of Cardiology2003;91:2-8

[4] Carlisle MA,DeVore AD.Heart Failure and atrial fibrillation, like fire and fury.JACC Heart Fail2019;7:447-56

[5] Colvin M,Ahn Y.OPTN/SRTR 2019 annual data report: heart.Am J Transplant2021;21 Suppl 2:356-440

[6] Rose EA,Moskowitz AJ.Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Study Group. Long-term use of a left ventricular assist device for end-stage heart failure.N Engl J Med2001;345:1435-43

[7] Lietz K,Kfoury AG.Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection.Circulation2007;116:497-505

[8] Long JW,Slaughter MS.Long-term destination therapy with the HeartMate XVE left ventricular assist device: improved outcomes since the REMATCH study.Congest Heart Fail2005;11:133-8

[9] Hamed S,Mueller F.Implementation of an intensified outpatient follow-up protocol improves outcomes in patients with ventricular assist devices.Clin Res Cardiol2019;108:1197-207

[10] Hanke JS,Zoch A.One-year outcomes with the HeartMate 3 left ventricular assist device.J Thorac Cardiovasc Surg2018;156:662-9

[11] Chakaramakkil MJ.ECMO and short-term support for cardiogenic shock in heart failure.Curr Cardiol Rep2018;20:87

[12] Richardson AS,Bailey M,Rycus PT.ECMO Cardio-Pulmonary Resuscitation (ECPR), trends in survival from an international multicentre cohort study over 12-years.Resuscitation2017;112:34-40

[13] Yang JH,Ko YG.Clinical characteristics and predictors of in-hospital mortality in patients with cardiogenic shock: results from the RESCUE registry.Circ Heart Fail2021;14:e008141

[14] Enriquez AD,Gandhi PU,Anyanwu AC.Clinical impact of atrial fibrillation in patients with the HeartMate II left ventricular assist device.J Am Coll Cardiol2014;64:1883-90

[15] Stulak JM,Schirger J.Preoperative atrial fibrillation increases risk of thromboembolic events after left ventricular assist device implantation.Ann Thorac Surg2013;96:2161-7

[16] Hickey KT,Mancini DM.Atrial fibrillation in patients with left ventricular assist devices: incidence, predictors, and clinical outcomes.JACC Clin Electrophysiol2016;2:793-8

[17] Deshmukh A,Burke M.Atrial arrhythmias and electroanatomical remodeling in patients with left ventricular assist devices.J Am Heart Assoc2017;6:e005340 PMCID:PMC5524037

[18] Colombo PC,Goldstein DJ.Comprehensive analysis of stroke in the long-term cohort of the MOMENTUM 3 Study.Circulation2019;139:155-68

[19] Cho SM,Teuteberg J.Understanding risk factors and predictors for stroke subtypes in the ENDURANCE trials.J Heart Lung Transplant2020;39:639-47

[20] Chiang YP,Schroder JN.Stroke risk following implantation of current generation centrifugal flow left ventricular assist devices.J Card Surg2020;35:383-9

[21] Galand V,Auffret V.Early ventricular arrhythmias after lvad implantation is the strongest predictor of 30-day post-operative mortality.JACC Clin Electrophysiol2019;5:944-54

[22] Blumer V,Kittipibul V.Impact of atrial fibrillation on in-hospital mortality and thromboembolic complications after left ventricular assist device implantation.J Cardiovasc Transl Res2021;14:120-4

[23] Tahsili-Fahadan P,Davis AA.Cerebrovascular events after continuous-flow left ventricular assist devices.Neurocrit Care2018;29:225-32

[24] Parikh NS,Karas MG,Kamel H.Stroke risk and mortality in patients with ventricular assist devices.Stroke2016;47:2702-6 PMCID:PMC5079813

[25] Sherazi S,Francis C.Prospective analysis of bleeding events in left ventricular assist device patients.Int J Artif Organs2018;41:269-76

[26] Papathanasiou M,Lortz J.Prolonged mechanical ventilation after left ventricular assist device implantation: risk factors and clinical implications.ESC Heart Fail2019;6:545-51 PMCID:PMC6487691

[27] Hickey KT,Naka Y.Atrial fibrillation is associated with recurrent ventricular arrhythmias after lvad implant: incidence and impact in a consecutive series.J Cardiovasc Transl Res2020;13:199-203

[28] Brenyo A,Koneru S.Risk of mortality for ventricular arrhythmia in ambulatory LVAD patients.J Cardiovasc Electrophysiol2012;23:515-20

[29] Iwasaki K,Murata S.Effect of the creatinine excretion rate index, a marker of sarcopenia, on prediction of intracranial hemorrhage in patients with advanced heart failure and a continuous-flow left ventricular assist device.Circ J2020;84:949-57

[30] Deshmukh A,Anyanwu E.Incidence and outcomes of postoperative atrial fibrillation after left ventricular assist device.ASAIO J2018;64:581-5 PMCID:PMC7055419

[31] Noll AE,Amuthan R.Atrial tachyarrhythmias among patients with left ventricular assist devices: prevalence, clinical outcomes, and impact of rhythm control strategies.JACC Clin Electrophysiol2019;5:459-66

[32] Gonuguntla K,Rojulpote C.A population based analysis of trends, risk factors and outcomes associated with gastrointestinal bleeding in patients with left ventricular assist devices.Am J Cardiovasc Dis2020;10(3):247-257 PMCID:PMC7486528

[33] Imamura T,Ono M.Implication of preoperative existence of atrial fibrillation on hemocompatibility-related adverse events during left ventricular assist device support.Circ J2019;83:1286-92

[34] Joy PS,Guddati AK,Cadaret LM.Risk factors and outcomes of gastrointestinal bleeding in left ventricular assist device recipients.Am J Cardiol2016;117:240-4

[35] Morgan JA,Xuereb L.Outcomes on continuous flow left ventricular assist devices: a single institutional 9-year experience.Ann Thorac Surg2016;102:1266-73

[36] Xuereb L,Kaur B.Impact of preoperative atrial fibrillation on postoperative thromboembolic events after left ventricular assist device implantation.Ann Thorac Surg2016;102:1543-9

[37] Acharya D,Morgan CJ.Intermacs analysis of stroke during support with continuous-flow left ventricular assist devices: risk factors and outcomes.JACC Heart Fail2017;5:703-11 PMCID:PMC5743224

[38] Hui J,Stulak JM,Maltais S.Intensive care unit readmission after left ventricular assist device implantation: causes, associated factors, and association with patient mortality.Anesth Analg2019;128:1168-74

[39] Hawkins RB,Guo A.Virginia Cardiac Services Quality Initiative. Postoperative atrial fibrillation is associated with increased morbidity and resource utilization after left ventricular assist device placement.J Thorac Cardiovasc Surg2018;156:1543-1549 PMCID:PMC6156995

[40] Teuteberg JJ,Rogers JG.ADVANCE Trial Investigators. The HVAD left ventricular assist device: risk factors for neurological events and risk mitigation strategies.JACC Heart Fail2015;3:818-28

[41] Xia Y,Friedmann P.Preoperative atrial fibrillation may not increase thromboembolic events in left ventricular assist device recipients on midterm follow-up.J Heart Lung Transplant2016;35:906-12

[42] Martins RP,Bourenane H.Incidence, predictors, and clinical impact of electrical storm in patients with left ventricular assist devices: new insights from the ASSIST-ICD study.Heart Rhythm2019;16:1506-12

[43] Kurihara C,Kawabori M,Civitello AB.Effect of preoperative atrial fibrillation on patients with chronic heart failure who undergo long-term continuous-flow LVAD implantation.ASAIO J2018;64:594-600

[44] Nassif ME,Raymer DS.Relationship between anticoagulation intensity and thrombotic or bleeding outcomes among outpatients with continuous-flow left ventricular assist devices.Circ Heart Fail2016;9:e002680 PMCID:PMC4860612

[45] Izzy S,Ahmed FS.Cerebrovascular accidents during mechanical circulatory support: new predictors of ischemic and hemorrhagic strokes and outcome.Stroke2018;49:1197-203

[46] Brisco MA,Milano CA.HeartMate II Clinical Investigators. Incidence, risk, and consequences of atrial arrhythmias in patients with continuous-flow left ventricular assist devices.J Card Surg2014;29:572-80

[47] Morris AA,Wittersheim K.Gender differences in the risk of stroke during support with continuous-flow left ventricular assist device.J Heart Lung Transplant2015;34:1570-7

[48] Dang NC,Kim BT,Kay J.Clinical outcomes in patients with chronic congestive heart failure who undergo left ventricular assist device implantation.J Thorac Cardiovasc Surg2005;130:1302-9

[49] Kittipibul V,Kewcharoen J,Vutthikraivit W.Atrial fibrillation is not associated with thromboembolism in left ventricular assist device patients: A Systematic Review and Meta-Analysis.ASAIO J2019;65:456-64

[50] Tantrachoti P,Vutthikraivit W,Gongora E.Impact of preoperative atrial fibrillation in patients with left ventricular assist device: a systematic review and meta-analysis.Artif Organs2019;43:1135-43

[51] Usman MS,Yamani N.Meta-analysis of the effect of preoperative atrial fibrillation on outcomes after left ventricular assist device implantation.Am J Cardiol2019;124:158-62

[52] Efimova E,Bertagnolli L.Predictors of ventricular arrhythmia after left ventricular assist device implantation: a large single-center observational study.Heart Rhythm2017;14:1812-9

[53] Hu RTC,Osawa EA.30-Day outcomes post Veno-Arterial Extra Corporeal Membrane Oxygenation (VA-ECMO) after cardiac surgery and predictors of survival.Heart Lung Circ2020;29:1217-25

[54] Vigneshwar NG,Lucas MT.Clinical predictors of in-hospital mortality in venoarterial extracorporeal membrane oxygenation.J Card Surg2020;35:2512-21

[55] Sonu G,Bishoy H.The impact of atrial fibrillation on in-hospital outcomes in patients with acute myocardial infarction complicated by cardiogenic shock undergoing coronary revascularization with percutaneous ventricular assist device support.J Atr Fibrillation2020;12:2179 PMCID:PMC7237086

[56] Abdullah KQA,Vom Dahl J.Cardiac arrhythmias in survivors of sudden cardiac death requiring impella assist device therapy.J Clin Med2021;10:1393 PMCID:PMC8037009

[57] Mehra MR.The burden of haemocompatibility with left ventricular assist systems: a complex weave.Eur Heart J2019;40:673-7

[58] Pedde D,Stein J.Impact of preoperative atrial fibrillation on thromboembolic events and pump thrombosis in long-term left ventricular assist device therapy.Eur J Cardiothorac Surg2020;57:325-30

[59] Oezpeker C,Pühler T,Gummert JF.Permanent atrial fibrillation and 2 year clinical outcomes in patients with a left ventricular assist device implant.ASAIO Journal2017;63:419-24

[60] Hollis IB,Jennings DJ.Pharmacotherapy for durable left ventricular assist devices.Pharmacotherapy2021;41:14-27

[61] Adatya S.Anticoagulation management in mechanical circulatory support.J Thorac Dis2015;7:2129-38 PMCID:PMC4703699

[62] Netuka I,Tučanová Z.Evaluation of low-intensity anti-coagulation with a fully magnetically levitated centrifugal-flow circulatory pump-the MAGENTUM 1 study.J Heart Lung Transplant2018;37:579-86

[63] Deng MC,Hertz MI.Mechanical circulatory support device database of the international society for heart and lung transplantation: second annual report--2004.J Heart Lung Transplant2004;23:1027-34

[64] Deng MC,Hertz MI.International Society for Heart and Lung Transplantation. Mechanical circulatory support device database of the International Society for Heart and Lung Transplantation: third annual report--2005.J Heart Lung Transplant2005;24:1182-7

[65] Zhang RS,Peters CJ.Left ventricular assist device as a bridge to recovery: single center experience of successful device explantation.ASAIO J2022;68:822-8

[66] Antonides CFJ,de By TMMH.EUROMACS investigators. Outcomes of patients after successful left ventricular assist device explantation: a EUROMACS study.ESC Heart Fail2020;7:1085-94 PMCID:PMC7261531

[67] Miyagawa S,Nakamura T.Building a bridge to recovery: the pathophysiology of LVAD-induced reverse modeling in heart failure.Surg Today2016;46:149-54

[68] Maybaum S,Xydas S.LVAD Working Group. Cardiac improvement during mechanical circulatory support: a prospective multicenter study of the LVAD Working Group.Circulation2007;115:2497-505

[69] Klotz S,Burkhoff D.Impact of left ventricular assist device (LVAD) support on the cardiac reverse remodeling process.Prog Biophys Mol Biol2008;97:479-96